| Andrea M Garcia, LPC | |
|
3031 W Ih 10, San Antonio, TX 78201-5159 | |
| (210) 731-1300 | |
| (210) 738-8025 |
| Full Name | Andrea M Garcia |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 3031 W Ih 10, San Antonio, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003157819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 67052 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea M Garcia, LPC 3031 W Ih 10, San Antonio, TX 78201-5159 Ph: (210) 731-1300 | Andrea M Garcia, LPC 3031 W Ih 10, San Antonio, TX 78201-5159 Ph: (210) 731-1300 |
News Archive
A research team led by Professor Lim Chwee Teck from the National University of Singapore's Department of Biomedical Engineering and Institute for Health Innovation & Technology, in collaboration with clinical partners from Singapore General Hospital, has developed a smart wearable sensor that can conduct real-time, point-of-care assessment of chronic wounds wirelessly via an app.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
Nanomedical Diagnostics, a cutting-edge life science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of a new NTA biosensor chip for use with its label-free Agile R100 assay system.
Novartis announced today that the US Food and Drug Administration has approved Entresto™ tablets, previously known as LCZ696, to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction.
› Verified 4 days ago
Paul Cassidy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7272 Wurzbach Rd Ste 601, San Antonio, TX 78240 Phone: 210-615-3483 | |
Cassandra Iris Limon, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4242 Medical Dr, San Antonio, TX 78229 Phone: 210-734-9352 | |
Terri Kurpgeweit, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7300 Blanco Rd, 501, San Antonio, TX 78216 Phone: 210-764-3570 | |
Elizabeth Marie Villarreal, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 530 San Pedro Ave, San Antonio, TX 78212 Phone: 210-558-8744 | |
Laura L Brown, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3031 W Ih 10, San Antonio, TX 78201 Phone: 210-731-1300 Fax: 210-731-8678 | |
Kelly D Mitchell, LCDC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3031 W Ih 10, San Antonio, TX 78201 Phone: 210-261-1024 Fax: 210-738-8025 |